The PreOncology Program™
Personalized cancer prevention built on whole genome sequencing, precision risk assessment, and continuous clinical guidance.
How the Program Works
Primary care physicians introduce the PreOncology Program to their patients. Interested patients register in the PreOncology Platform™ and begin with the Stage Alpha Assessment, the entry point into the program.
Using whole genome sequencing, advanced cancer risk modeling, family history, lifestyle factors, and clinical data, PreOncology™ creates a personalized cancer prevention and early detection strategy designed around the members unique biology.
The Stage Alpha Assessment
Step 1
Blood Draw
A single blood draw that produces a oncology specific genomic analysis that is more comprehensive than any hereditary cancer risk genetic testing currently available. This test is performed once and continuously reinterpreted as science advances.
Step 2
Precision Risk Assessment
A structured clinical intake capturing personal and family history, lifestyle factors, and other clinically relevant inputs used to build each member’s risk profile.
Step 3
Initial Consultation with the Prevention Care Team
A dedicated review session in which the Prevention Care Team presents the member’s personalized risk profile and individualized prevention plan. The team includes a board-certified medical oncologist or nurse practitioner specializing in prevention and early detection, and an oncology-specialized genetic counselor.
Following the Initial Consultation, a full report is presented to the member and their primary care physician through the PreOncology Platform.
Recommended Program Assignment
Based on the findings of the Stage Alpha Assessment, members may be recommended for ongoing surveillance through one of three prevention programs based on their individual risk profile. Every test, scan, and evaluation is coordinated within the program, so members are never left managing fragmented testing on their own.
Elevated Risk
Baseline Program
Designed for individuals whose cancer risk exceeds the general population and may benefit from ongoing surveillance.
- Whole-body MRI surveillance
- Biomarker surveillance
- Two Prevention Care Team visits per year
- Annual protocol review and risk reassessment
- Personalized prevention recommendations
- Signal Board review and management of abnormal findings
High Risk
Core Program
Designed for individuals whose cancer risk warrants intensified surveillance and more frequent clinical monitoring.
- Whole-body MRI surveillance
- Enhanced biomarker surveillance
- Two Prevention Care Team visits per year
- Ongoing protocol optimization
- Continuous risk reassessment
- Personalized surveillance protocols based on risk
- Signal Board review and management of abnormal findings
Very High Risk
Advanced Program
Designed for individuals with substantial cancer risk who require the highest level of surveillance and clinical oversight.
- Expanded whole-body MRI and targeted imaging strategy
- Expanded biomarker surveillance
- Three Prevention Care Team visits per year
- Continuous protocol optimization
- Continuous risk reassessment
- Personalized surveillance protocols based on risk
- Enhanced Signal Board oversight
Screening Technologies
